Tharimmune, Inc. — Director's Dealing 2025

Aug 20, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Tharimmune, Inc. (THAR)
CIK: 0001861657
Period of Report: 2025-04-09

Reporting Person: LoPriore Vincent S (Director, Executive Chairman, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	732424	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1.33	2035-08-04	Common Stock (100000)		Direct
Series A Warrants (right to buy)	$1.29	2030-12-20	Common Stock (337838)		Indirect
Series B Warrants (right to buy)	$3.00	2030-12-20	Common Stock (168918)		Indirect
Common Stock Purchase Warrants	$2.03	2030-06-09	Common Stock (443806)		Indirect

Footnotes

F1: The reported shares are owned directly by Gravitas Capital LP, a limited partnership of which Gravitas Capital Partners LLC is the sole general partner. The reporting person is the managing member of Gravitas Capital Partners LLC. The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.

F2: 50,000 of the options vest on date of grant and 50,000 vest on August 4, 2026.